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SUMMARY
National policies for chemoprophylaxis after single cases of meningococcal disease in day-care
or nursery settings vary across Europe. We carried out a multi-national retrospective study to
compare the eﬀectiveness of diﬀerent policies. Countries were divided into those recommending
chemoprophylaxis only to close contacts (policy A, close) and those recommending
chemoprophylaxis for all children in the same nursery (policy B, mass). Country-speciﬁc relative
risk (RR) of a cluster was deﬁned as the ratio of the number of clusters observed to the number
of clusters expected by chance. In total, 37 clusters were identiﬁed between 1 January 1993 and
31 December 2002. After adjusting for marked heterogeneity in RR by country, the ratio of RR
between countries suggested possible beneﬁt from mass prophylaxis (RR ratio 3.8, 95% CI
0.7–22.0), although the diﬀerence was not statistically signiﬁcant (P=0.22). The costs of
this approach and the low risk of clustering need to be taken into account when deciding
national policy.
INTRODUCTION
Clusters of meningococcal disease are rare in child-
care or nursery schools [1], but cause high levels of
public and professional concern. In 1995 an enhanced
surveillance system was set up in England & Wales to
detect clusters of meningococcal disease in pre-school
and school settings through retrospective and
prospective reporting of clusters at district level. In
6 years of observation this system detected 20 clusters
in nursery schools. The relative risk of clusters in the 4
weeks after a single case in nursery schools compared
to the age-speciﬁc background risk was 28 (95% CI
15–40), an absolute risk to an individual in a nursery
school of 70/105 [2]. Nearly 30% of cases occurred
within 2 days after a single case, and 68% within the
ﬁrst 7 days. The risk of further cases and the short
time-interval between cases underlines the need for
rapid implementation of any control measures.
In 2000 the European Monitoring Group on
Meningococci (EMGM) Public Health Policy
Working Group reviewed the eﬀectiveness of
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chemoprophylaxis in preventing further cases of
meningococcal disease. Chemoprophylaxis reduced
the risk of further cases in household contacts by 90%
during the ﬁrst month after a case [3]. No studies were
found that evaluated the eﬀectiveness of such policies
in nursery schools. This lack of evidence has led to
two main approaches to policy across Europe once a
single case occurs : giving chemoprophylaxis either to
close contacts of the case only (policy A) or to all
children attending the same nursery (policy B).
With the aim of improving coordination of
infectious disease control and informing prevention
policies in Europe, we carried out a study to assess the
eﬀectiveness of these two policies by comparing the
incidence of clusters of meningococcal disease in
European countries according to the policy used.
METHODS
All 38 countries in the EMGM and/or the European
Invasive Bacterial Infections Surveillance Network
were invited to participate in a retrospective cohort
study. The cohort comprised those children in the
study countries who attended ‘nursery schools ’ (for
deﬁnitions see Table 1) with at least one case of
meningococcal disease between January 1993 and
December 2002. The outcome of interest was the
number of clusters in nursery schools for each
country.
Data collection was run in two phases: Phase 1 was
a feasibility survey by email to assess data availability
and willingness to participate. Phase 2 involved the
collection of the data. The minimum set of data
required for Phase 2 included information about
clusters in nursery schools, surveillance information
on laboratory-conﬁrmed cases of meningococcal dis-
ease (number of cases aged 0–6 years by year of age),
numbers of children (0–6 years) by year of age in the
population, number of nursery schools, and number
or proportion of children attending nursery schools.
In Phase 2, these data were requested from each
country for 1994, 1997 and 2001, but information on
clusters were requested for the full 10-year period.
Data on clusters of meningococcal disease included
number of cases in the cluster, date of onset of each
case, age of cases and serogroup of the causative
strains. Countries were also asked for deﬁnitions of
cases of meningococcal disease, close contacts and
clusters. Data about prophylaxis policy adopted after
a single case in a nursery school were also collected,
including year of implementation, type and dosage of
antibiotic administered, target group for prophylaxis,
Table 1. Deﬁnitions adopted for the purpose of the study
Term Deﬁnition
Cluster Two or more laboratory-conﬁrmed cases of meningococcal disease within 4 weeks in children
attending the same nursery school
Nursery school Kindergarten, nursery or day-care centre attended by children of pre-school age (0–6 years)
Close contacts Those living and/or sleeping in the same household-like setting
Policy B Eﬀective chemoprophylaxis provided to all children in a nursery school after a single case of
meningococcal disease
Policy A Eﬀective prophylaxis only to close contacts after a single case of meningococcal disease
occurs or adoption of ineﬀective chemoprophylaxis
Eﬀective
chemoprophylaxis Drug Dosage
Duration and route
of administration
Rifampicin 10 mg/kg (children
1–12 years), 5 mg/kg
(<12 months of age)
Twice daily for
2 days, orally
Ceftriaxone 125 mg/kg (children
<15 years)
Single dose, intramuscular
Ciproﬂoxacin 20 mg/kg Single dose, orally
Ineﬀective
chemoprophylaxis
Penicillin, ampicillin, nalidixic acid, erythromycin, chloramphenicol
Exposed Those nursery schools where policy B is adopted after a single case of meningococcal disease
Non-exposed Those nursery schools where policy A is adopted after a single case of meningococcal disease
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and any use of vaccine. Ineﬀective prophylaxis
(Table 1) was recorded as not given.
For each country the relative risk of a cluster was
estimated as the ratio of the number of clusters ob-
served over the number of clusters expected by chance
(Table 2). The method allowed adjustment for the
number of children in the population, age group of
children attending nurseries and background inci-
dence of meningococcal disease. The risk ratio of a
cluster according to policy used was deﬁned as the
ratio of the relative risk of a cluster among countries
adopting policy A to the relative risk of a cluster
among countries adopting policy B (Table 2).
As data on nursery school size in several countries
was not available, the analysis was carried out
assuming that all countries had the same nursery size
using the median value of those countries that were
able to provide this data. Heterogeneity between
relative risk in countries using policy A or policy B
was examined by testing for evidence of over-
dispersion in a Poisson regression model. The data
were re-analysed after adjustment for heterogeneity
by rescaling the variance in the model by the ratio of
the deviance and residual degrees of freedom. As data
from France indicated that mean size of ‘maternelles ’
was 95 and as policy in France was to recommend
prophylaxis only for the same class (mean size 27),
the country was assigned to policy B and cluster
deﬁnition was restricted to cases in the same class.
RESULTS
Among the 38 countries initially invited to partici-
pate, 22 returned the feasibility questionnaire. Of
these, 12 were able to provide the minimum dataset
and were therefore included in Phase 2 (Austria,
Czech Republic, Denmark, France, Italy, Norway,
Portugal, Republic of Ireland, Scotland, Spain,
Sweden, England & Wales). Nine countries reported
using policy A, and ﬁve policy B (England & Wales
and Austria were counted twice as they changed
policy during the study period) (Table 3). More than
8 million children were included in the cohort. The
overall number of nurseries was y237 000 and the
median nursery size was 38 (range 22–74). The esti-
mated annual rate of meningococcal disease per 1000
nurseries was quite low, ranging between 0.01 (Italy)
and 1.29 (Portugal).
Thirty-seven clusters of meningococcal disease in
nurseries were observed, 31 from countries using
policy A and six from countries adopting policy B
(Table 4). England & Wales was the country with the
highest number of clusters reported. There was
variability in country-speciﬁc relative risk of a cluster,
ranging between 0 and 75.9 (Table 4, Fig.). The mean
absolute risk of clusters was 0.9/100 primary cases in
countries using policy A and 0.3/100 in those using
policy B. The overall number of expected clusters was
1.53 and 1.12 for countries using policy A and B
Table 2. Formulas adopted to estimate relative risk of clusters by country and relative risk ratio by policy
Expected number of cases in nurseries
during the observation period (N1)
N1=SA number of cases aged Arproportion of children aged A attending
nursery
Expected number of cases in a
single nursery during the observation
period (N2)
N2=N1/number of nurseries
Probability of 2, 3 cases within a
single nursery by chance (P2, P3)
P2=exp (xN2)rN22/2, (calculated from the Poisson distribution with mean N2)
P3=exp (xN2)rN23/6
(Note : Probability of>3 cases
negligible)
Probability of 2, 3 chance cases form
a cluster of 2 cases within 4 weeks of
C2=8/total weeks of observation (8 derived from assigning a date to one
case then the next case must be within¡4 weeks of this date)
one another (C2, C3) C3=C2+(1xC2)r16/total weeks of observation (16 derived from
assigning dates for the ﬁrst two cases then the third case needs to
be within¡4 weeks of either of the ﬁrst two)
Expected number of nurseries with a
chance cluster (E)
E=Number of nurseriesr[(P2rC2)+(P3rC3)]
Country-speciﬁc relative risk (RR) of
cluster in a nursery
RR=O/E (O=no. observed clusters)
Relative risk ratio (RRR) of having a
cluster by policy
RRR=
S clusters observed=S clusters expected (for countries adopting policy A)
S clusters observed=S clusters expected (for countries adopting policy B)
874 D. Boccia and others
respectively, an overall risk ratio of 3.77. Testing for
over-dispersion showed signiﬁcant heterogeneity
between countries adopting the same policy
(P<0.001 for both policy A and B). After adjusting
for heterogeneity, the protective eﬀect of policy B was
not signiﬁcant (P=0.22).
DISCUSSION
This is the ﬁrst study to assess the eﬀectiveness of
diﬀerent chemoprophylaxis policies across Europe in
preventing clusters of meningococcal disease in
nursery schools. Although there was possible beneﬁt
after mass prophylaxis, the wide heterogeneity in risk
of clusters did not allow us to draw a ﬁrm conclusion.
Many factors can account for such heterogeneity
including (a) diﬀerent sensitivities in detection of
primary cases, (b) diﬀerent sensitivities in detecting
clusters, (c) diﬀerences in data quality. The overall
risk of clusters was low whatever the policy adopted.
One limitation of the study was the lack of accurate
national statistics on nursery schools, including
number of institutions, proportion of children
attending them and the nursery size. The dynamics of
meningococcal transmission in nursery-school set-
tings are not known, but it seems reasonable to think
that group size may well be one important determi-
nant of risk of clusters. Because of the lack of reliable
data we assumed all countries had the same nursery
size group and identiﬁed this number as the median of
the nursery size available. This assumption precluded
assessment of how this parameter aﬀects the country-
speciﬁc relative risk.
A protective eﬀect of widespread chemoprophy-
laxis is somehow intuitive and has been shown to be
eﬀective in household settings. A systematic review
suggested that chemoprophylaxis to household con-
tacts reduced by 90% the risk of meningococcal dis-
ease after a case occurred [3]. However, the likelihood
and type of contact in nursery schools and risk of
transmission may diﬀer from those in the household.
If mass chemoprophylaxis is protective in the nursery
setting, other factors need to be considered before
such a policy is advised in nursery schools. One factor
is the actual risk of having a cluster after a single case
[4] (less than 1% in our study), another is the econ-
omic cost of treating the whole nursery school after a
case has occurred [5]. Due to the high concern about
meningococcal disease, it is likely that the general
public would accept substantial ﬁnancial costs, but
costs of widespread use of antibiotics are not only
ﬁnancial. The higher the numbers of children treated,
the higher the risk of adverse events and development
of antimicrobial resistance [6, 7]. Moreover, the
widespread use of antibiotics would be expected to
clear carriage of Neisseria lactamica in children,
potentially interfering with natural development of
immunity against meningococcal infection [8].
Table 3. Chemoprophylaxis policy adopted by country
Country
Year of
implementation Vaccination* Drugs used#
Policy A 2000 Yes Rif, Ctx, Cip
Austria 1993 Yes Pen
Czech Republic 1992 Yes Cip, Rif, Ctx
Denmark 1980 Yes Rif, Ctx, Cip
Italy 1989 Yes Pen
Norway 1995 Yes Rif, Cip
Scotland Not mentioned Yes Rif, Ctx, Cip
Spain 1993 Yes Rif, Cip, Pen
Sweden 1995 Yes Rif, Cip
England & Wales
Policy B
Austria Not mentioned Yes Rif, Ctx, Cip
Ireland 1999 Yes Rif, Ctx
Portugal 1998 No Rif
France 1990 Yes Rif
England & Wales 1993–1995 Yes Rif
* Use of vaccine combined with chemoprophylaxis.
# Rif, Rifampicin ; Ctx, ceftriaxone ; Pen, penicillin ; Cip, ciproﬂoxacin.
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An alternative policy, as adopted in one country,
would be to restrict prophylaxis to a subgroup of
children of similar age sharing the same room within
a nursery.
In conclusion, while our ﬁndings support possible
beneﬁt from mass chemoprophylaxis after a single
case in nursery schools, marked heterogeneity of
relative risk between countries does not provide clear
evidence of beneﬁt. The low risk of clustering in this
setting and potential adverse eﬀects from widespread
antibiotic treatment should be considered when de-
ciding policy on chemoprophylaxis.
Surveillance systems able to provide reliable
and comparable data on cases and clusters of
Table 4. Relative risk ratio of cluster of meningococcal disease in nursery schools in countries using policy A or B,
1993–2002
Policy Country
Estimated no. of
primary cases
No. of clusters
RR* 95% CIExpected Observed
A Austria# 22 0.0025 0 0.0 0.0–1489
Czech Republic 119 0.0160 0 0.0 0.0–23
Denmark 407 0.2399 7 29.2 11.7–60
Italy 41 0.0007 0 0.0 0.0–5366
Norway 119 0.0234 1 42.7 1.1–239
Scotland 261 0.1256 0 0.0 0.0–29
Spain 1702 0.8554 7 8.2 3.3–17
Sweden 41 0.0013 0 0.0 0.0–2908
England & Wales# 680 0.2660 16 60.1 34.2–92
Total 1.530 31
B Austria 56 0.0063 0 0.0 0.0–583
France 890 0.0741 0 0.0 0.0–50
Ireland 588 0.9520 1 1.1 0.03–5.9
Portugal 177 0.0527 4 75.9 20.9–193
England & Wales 158 0.0325 1 30.8 0.8–172
Total 1.117 6
Expected Observed RRR$ 95% CI
Policy A 1.530 31 3.77 1.6–9.0
Policy B 1.117 6
After adjusting for heterogeneity 3.77 0.7–22.0
* Relative risk of cluster by country.
# Included in policy A and B as changed policy during the observation period.
$ RRR, Relative risk ratio.
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Fig. Relative risk (RR) of a cluster in nursery schools by country using policy A or policy B.
876 D. Boccia and others
meningococcal disease in Europe are necessary to
increase the validity of risk comparisons between
countries.
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